Table 3.
Variable | B | S.E | Wald | P | OR | 95% CI for OR |
---|---|---|---|---|---|---|
Parity | 0.085 | 0.201 | 0.179 | 0.672 | 1.089 | 0.734–1.615 |
Menopausal Status | -0.426 | 0.369 | 1.327 | 0.249 | 0.653 | 0.317–1.348 |
Clinical Symptoms | 2.804 | 0.246 | ||||
Contact Bleeding | -0.413 | 0.396 | 1.087 | 0.297 | 0.661 | 0.304–1.439 |
Irregular Vaginal Bleeding | -0.804 | 0.485 | 2.747 | 0.097 | 0.448 | 0.173–1.158 |
SCCAg | -0.399 | 0.153 | 6.814 | 0.009* | 0.671 | 0.497–0.905 |
CA125 | -0.001 | 0.005 | 0.031 | 0.861 | 0.999 | 0.989–1.010 |
CA19-9 | 0.030 | 0.016 | 3.539 | 0.060 | 1.030 | 0.999–1.063 |
CYFRA 21–1 | -0.174 | 0.142 | 1.496 | 0.221 | 0.841 | 0.636–1.110 |
CEA | 0.003 | 0.010 | 0.089 | 0.765 | 1.003 | 0.983–1.024 |
HPV | 59.676 | < 0.001* | ||||
Medium Risk | 0.895 | 0.724 | 1.526 | 0.217 | 2.445 | 0.592–10.119 |
High Risk | 2.982 | 0.386 | 59.613 | < 0.001* | 19.722 | 9.252–42.040 |
*A p value of < 0.05 was considered to indicate significant difference